Pure Global AI
Manufacturer profile

LEICA BIOSYSTEMS NEWCASTLE LTD

BrazilUnited Kingdom19 ANVISA registrations17 unique technical categoriesJul 02, 2018 – Feb 18, 2026
Verified
19
Total products
17
Technical names
Jul 2018
Earliest registration
Feb 2026
Latest registration
Regulatory footprint
Search LEICA BIOSYSTEMS NEWCASTLE LTD across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
Sonda CMV
Class IV · Feb 18, 2026
SONDAS PARA MARCADORES DE PATOLOGIAS E NEOPLASIAS DO SISTEMA REPRODUTOR
Família Sonda marcadora de patologias e neoplasias do sistema reprodutor
Class III · Feb 18, 2026
MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES)
Controle HER2 FISH
Class III · Jul 21, 2025
MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES)
Família Sonda Controle RNA
Class III · Jul 21, 2025
IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS
Família Anticorpo para Carcinoma Germinativo
Class III · Nov 23, 2020
Most popular products
Products with most registrations
MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES)
3 registrations
HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
1 registrations
SONDAS PARA MARCADORES DE PATOLOGIAS E NEOPLASIAS DO SISTEMA REPRODUTOR
1 registrations
IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS
1 registrations
IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA.
19 products
Top competitors
Companies with the most overlapping products (same technical names)
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
Singapore
21 registrations13 shared products
Shared products
COMPANION DIAGNOSTICS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS, IMMUNOHISTOCHEMISTRY - THYROID/PARATHYROID CARCINOMA MARKERS, IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS, MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES), PROBES FOR LEUKEMIA AND LYMPHOMA MARKERS
VENTANA MEDICAL SYSTEM, INC
United States
27 registrations11 shared products
Shared products
COMPANION DIAGNOSTICS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS, IMMUNOHISTOCHEMISTRY - THYROID/PARATHYROID CARCINOMA MARKERS
AGILENT TECHNOLOGIES, INC.
United States
16 registrations9 shared products
Shared products
COMPANION DIAGNOSTICS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - COMPLEMENTARY REAGENTS, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS, IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS
CELL MARQUE CORPORATION
United States
17 registrations8 shared products
Shared products
IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - LYMPHOMA AND LEUKEMIA MARKERS, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR GASTROINTESTINAL TRACT CARCINOMAS, IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS, IMMUNOHISTOCHEMISTRY - MARKERS OF NERVOUS SYSTEM CARCINOMAS, IMMUNOHISTOCHEMISTRY - MUSCLE CARCINOMA AND MUSCULAR DISORDER MARKERS, IMMUNOHISTOCHEMISTRY - PROSTATE CARCINOMA MARKERS
ROCHE DIAGNOSTICS GMBH
Germany
20 registrations5 shared products
Shared products
COMPANION DIAGNOSTICS, HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS, IMMUNOHISTOCHEMISTRY - CARCINOMA MARKERS IN GENERAL, IMMUNOHISTOCHEMISTRY - MARKERS FOR BREAST CARCINOMAS, MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES)
About this profile

Explore comprehensive manufacturer profile for LEICA BIOSYSTEMS NEWCASTLE LTD based in United Kingdom through Pure Global AI's free Brazil medical device database. This manufacturer has 19 products registered with ANVISA across 17 unique technical categories. Their regulatory history spans from Jul 02, 2018 to Feb 18, 2026.

This page provides detailed insights including 5 recent product registrations including HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS, 5 most popular products with MUTATIONS (GENIC, STRUCTURAL, NUMERICAL OR ANEUPLOIDIES) having 3 registrations, 1 registration holders including LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA., and 5 key competitors with AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD. sharing 13 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.